SUTENT Side Effects

7023232-5 | Amnesia, Blood Pressure Increased, Cerebral Haemorrhage, Dyspnoea, Headache, Hyperhidrosis, Hypokalaemic Syndrome, Muscular Weakness, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 21, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, blood pressure increased, cerebral haemorrhage, dyspnoea, headache (What is headache?), hyperhidrosis, hypokalaemic syndrome, muscular weakness, palmar-plantar erythrodysaesthesia syndrome. Sutent dosage: 50 Mg, 1x/day, For 28 Days Evey 42 Days. Patient was hospitalized.

7023228-3 | Gastrointestinal Disorder, Sensory Disturbance
Patient was taking Sutent (View Usage). Patient had the following side effects: gastrointestinal disorder, sensory disturbance on Sep 21, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 280.0 lb, was diagnosed with renal cell carcinoma and. Sutent dosage: 37.5 Mg, Unk.

7023223-4 | Cholelithiasis, Renal Failure
Adverse event was reported on Sep 22, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, Daily) was diagnosed with gastrointestinal stromal tumour, gastric disorder and. Location: UNITED STATES , weighting 150.0 lb, After Sutent was administered, patient had the following side effects: cholelithiasis, renal failure. During the same period patient was treated with VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ), RANITIDINE (150 Mg, Daily) (View Ranitidine Review and Ranitidine Label ), OMEPRAZOLE (20 Mg, Daily) (View Omeprazole Review and Omeprazole Label ).

7023192-7 | Cytolytic Hepatitis
on Sep 23, 2010 Female patient from FRANCE , 65 years of age, weighting 385.8 lb, was diagnosed with glioblastoma, anxiety (What is anxiety?) and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Sutent dosage: Unk. During the same period patient was treated with MEDROL (80 Mg, 1x/day) (View Medrol Review and Medrol Label ), SOLU MEDROL (80 Mg, 1x/day) (View Solu-medrol Review and Solu-medrol Label ), KEPPRA (100 Mg, 1x/day) (View Keppra Review and Keppra Label ), LYSANXIA (5 Mg, 1x/day) (View Lysanxia Review and Lysanxia Label ).


7023171-X | Dehydration, Lethargy
on Sep 20, 2010 Female patient from UNITED STATES , weighting 164.9 lb, was diagnosed with renal cancer, hepatic neoplasm malignant, diabetes mellitus and was treated with Sutent (View Usage). Patient had the following side effects: dehydration, lethargy. Sutent dosage: 37.5 Mg, 1x/day. During the same period patient was treated with METFORMIN (500 Mg, Unk) (View Metformin Review and Metformin Label ). Patient was hospitalized.

7022638-8 | Hypertension, Muscular Weakness
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: hypertension, muscular weakness on Sep 23, 2010 from ITALY Additional patient health information: Male patient , 68 years of age, was diagnosed with metastatic renal cell carcinoma and. Sutent dosage: 50 Mg.

7022637-6 |
Adverse event was reported on Sep 20, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day For 4 Weeks, Every 6 Weeks) was diagnosed with metastatic renal cell carcinoma and. Location: INDIA , 28 years of age, .

7022636-4 | Decreased Appetite, Diarrhoea, Myasthenia Gravis, Respiratory Failure, Swelling Face, Thyrotoxic Crisis
on Sep 21, 2010 Male patient from JAPAN , 45 years of age, weighting 180.8 lb, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). Patient had the following side effects: decreased appetite, diarrhoea, myasthenia gravis, respiratory failure, swelling face, thyrotoxic crisis. Sutent dosage: 50 Mg, 1x/day. Patient was hospitalized.

7022609-1 | Duodenal Ulcer, Gastrointestinal Haemorrhage, Nausea
on Sep 23, 2010 Male patient from GERMANY , 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: duodenal ulcer, gastrointestinal haemorrhage, nausea (What is nausea?). Sutent dosage: 50 Mg, 1x/day, 4 Weeks On/2 Weeks Off.

7022596-6 | Abdominal Discomfort, Dermatitis Exfoliative, Diarrhoea, Hypertension, Malaise, Thrombocytopenia
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, dermatitis exfoliative, diarrhoea, hypertension, malaise, thrombocytopenia on Sep 21, 2010 from HONG KONG Additional patient health information: Male patient , 43 years of age, was diagnosed with pancreatic neuroendocrine tumour and. Sutent dosage: 50 Mg, 1x/day, 4 Weeks Then Rest For 2 Weeks.

7022593-0 | Chest Pain, Disease Progression, Lung Infection, Metastatic Renal Cell Carcinoma, Pneumothorax, Pulmonary Necrosis
Adverse event was reported on Sep 23, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day For 4 Weeks Then 2 Weeks Off) was diagnosed with renal cell carcinoma and. Location: CANADA , 55 years of age, weighting 275.6 lb, Patient had the following side effects: chest pain (What is chest pain?), disease progression, lung infection, metastatic renal cell carcinoma, pneumothorax, pulmonary necrosis. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), RABEPRAZOLE (View Rabeprazole Review and Rabeprazole Label ), FLOMAX (View Flomax Review and Flomax Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

7022582-6 | Blood Creatinine Increased, Cognitive Disorder, Disease Progression, Fatigue, Haemoglobin Decreased, Listless, Renal Cancer Metastatic, Renal Failure, Somnolence
on Sep 21, 2010 Female patient from NORWAY , 66 years of age, was diagnosed with renal cancer metastatic and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: blood creatinine increased, cognitive disorder, disease progression, fatigue, haemoglobin decreased, listless, renal cancer metastatic, renal failure, somnolence. Sutent dosage: 50 Mg, Unk.

7022540-1 | Constipation, Dehydration, Disorientation, Dizziness, Fluid Retention, Glossodynia, Hypoglycaemia, Lip Blister, Lip Pain
on Sep 18, 2010 Male patient from COLOMBIA , 79 years of age, was diagnosed with hepatic neoplasm malignant, hepatic pain, dizziness (What is dizziness?), glossodynia and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), dehydration, disorientation, dizziness (What is dizziness?), fluid retention, glossodynia, hypoglycaemia, lip blister, lip pain. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with TRAMADOL (Unk) (View Tramadol Review and Tramadol Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ), LORATADINE (10 Mg, 1x/day) (View Loratadine Review and Loratadine Label ), METOCLOPRAMIDE (10 Mg, 1x/day) (View Metoclopramide Review and Metoclopramide Label ), NOVALGINA (500 Mg, As Needed) (View Novalgina Review and Novalgina Label ). Patient was hospitalized.

7021344-3 | Lower Extremity Mass, Yellow Skin
Patient was taking Sutent (View Usage). Patient had the following side effects: lower extremity mass, yellow skin on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 115.0 lb, was diagnosed with neoplasm, hypothyroidism and. Sutent dosage: Unk. During the same period patient was treated with LEVOTHYROXINE (70 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ).

7021308-X | Blood Pressure Increased
Adverse event was reported on Sep 17, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , weighting 125.0 lb, After Sutent was administered, patient had the following side effects: blood pressure increased. During the same period patient was treated with DILAUDID (2 Mg, Every 3 Hours) (View Dilaudid Review and Dilaudid Label ), COLACE (100 Mg, 1x/day) (View Colace Review and Colace Label ).

7021301-7 | Arthralgia, Myalgia, Urticaria
on Sep 22, 2010 Male patient from UNITED STATES , weighting 135.0 lb, was diagnosed with gastrointestinal stromal tumour, arthralgia, myalgia and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, myalgia, urticaria. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with NEURONTIN (100 Mg, 1x/day) (View Neurontin Review and Neurontin Label ), METOPROLOL (50 Mg, Unk) (View Metoprolol Review and Metoprolol Label ), PERCOCET (Unk) (View Percocet Review and Percocet Label ), GLYBURIDE (Unk) (View Glyburide Review and Glyburide Label ).

7021131-6 | Colitis, Dehydration, Pancreatitis, Pancytopenia, Renal Failure Acute
on Sep 22, 2010 Female patient from UNITED STATES , weighting 126.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). Patient had the following side effects: colitis, dehydration, pancreatitis, pancytopenia, renal failure acute. Sutent dosage: 50 Mg, 1x/day, 2 Weeks On/1 Weeks Off. During the same period patient was treated with LEVOTHYROXINE (50 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ), NIFEDIPINE (60 Mg, Daily) (View Nifedipine Review and Nifedipine Label ), IRON SULFATETHIAMIN COMPOUND TAB (Unk) (View Iron Sulfatethiamin Compound Tab Review and Iron Sulfatethiamin Compound Tab Label ), COMPAZINE (Unk) (View Compazine Review and Compazine Label ), LOTREL (5/20 Mg, Daily) (View Lotrel Review and Lotrel Label ), AMBIEN (5 Mg, Daily) (View Ambien Review and Ambien Label ). Patient was hospitalized.

7021078-5 | Anaemia, Chest Pain, Disease Progression, Malaise, Platelet Count Abnormal, Pruritus, Renal Cell Carcinoma, Weight Decreased
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: anaemia, chest pain (What is chest pain?), disease progression, malaise, platelet count abnormal, pruritus, renal cell carcinoma, weight decreased on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with renal cell carcinoma, abdominal discomfort, iron deficiency, gout (What is gout?), hypertension and. Sutent dosage: 12.5 Mg, 4x/day. During the same period patient was treated with RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ), POTASSIUM (10 Meq, Unk) (View Potassium Review and Potassium Label ), COLCHICINE (Unk) (View Colchicine Review and Colchicine Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), COZAAR (Unk) (View Cozaar Review and Cozaar Label ), LOSARTAN (Unk) (View Losartan Review and Losartan Label ).

7020989-4 | Immunosuppression, Respiratory Tract Infection
Adverse event was reported on Sep 21, 2010 by a Female patient taking Sutent (View Usage) (Dosage: Unk) was diagnosed with renal cell carcinoma and. Location: GREECE , 57 years of age, Patient experienced the following unwanted or unexpected effects: immunosuppression, respiratory tract infection.

7020876-1 | Tooth Infection
on Sep 21, 2010 Male patient from UNITED KINGDOM , 45 years of age, was diagnosed with metastatic renal cell carcinoma, post procedural pulmonary embolism and was treated with Sutent (View Usage). Patient had the following side effects: tooth infection. Sutent dosage: 50 Mg, Cyclic (4 Weeks On, 2 Weeks Off). During the same period patient was treated with TINZAPARIN SODIUM (Unk) (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ).

7020834-7 | Obliterative Bronchiolitis
on Sep 20, 2010 Male patient from SPAIN , 60 years of age, was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: obliterative bronchiolitis. Sutent dosage: 50 Mg, 1x/day, 4 Weeks On/2 Weeks Off.

7019637-9 | Haemoglobin Decreased, International Normalised Ratio Increased, Platelet Count Decreased
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, international normalised ratio increased, platelet count decreased on Sep 28, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 98.33 lb, was diagnosed with gastrointestinal stromal tumour and. Sutent dosage: 12.5 Mg 3 Times Daily Po. Patient was hospitalized.

7018881-4 | Constipation, Decreased Appetite, Diarrhoea, Disseminated Intravascular Coagulation, Encephalopathy, Failure To Thrive, Gastrointestinal Perforation, Megacolon, Mental Status Changes
Adverse event was reported on Sep 17, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , weighting 162.0 lb, Patient had the following side effects: constipation (What is constipation?), decreased appetite, diarrhoea, disseminated intravascular coagulation, encephalopathy, failure to thrive, gastrointestinal perforation, megacolon, mental status changes. During the same period patient was treated with POTASSIUM (View Potassium Review and Potassium Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ASPIRINE (View Aspirine Review and Aspirine Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ). Patient was hospitalized.

7018879-6 | Neuropathy Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome, Skin Exfoliation
on Sep 20, 2010 Male patient from UNITED STATES , weighting 259.9 lb, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: neuropathy peripheral, palmar-plantar erythrodysaesthesia syndrome, skin exfoliation. Sutent dosage: 37.5 Mg, 1x/day. During the same period patient was treated with DIOVAN HCT (Unk) (View Diovan Hct Review and Diovan Hct Label ), EFFEXOR (Unk) (View Effexor Review and Effexor Label ), LYRICA (Unk) (View Lyrica Review and Lyrica Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ).

7018877-2 | Gingival Swelling, White Blood Cell Count Decreased
on Sep 17, 2010 Male patient from JAPAN , 56 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: gingival swelling, white blood cell count decreased. Sutent dosage: 25 Mg, 1x/day.

7018868-1 | Thrombosis
Patient was taking Sutent (View Usage). Patient had the following side effects: thrombosis on Sep 21, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 304.9 lb, was diagnosed with renal cell carcinoma and. Sutent dosage: 50 Mg, Daily. Patient was hospitalized.

7018827-9 | Ulcer
Adverse event was reported on Sep 16, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, Unk) was diagnosed with metastatic renal cell carcinoma and. Location: FRANCE , 75 years of age, After Sutent was administered, patient had the following side effects: ulcer (What is ulcer?).

7018822-X | Cardiogenic Shock, Ejection Fraction Decreased, Myocardial Infarction
on Sep 21, 2010 Male patient from UNITED STATES , weighting 183.0 lb, was diagnosed with renal cancer and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, ejection fraction decreased, myocardial infarction. Sutent dosage: 50 Mg, 1x/day. Patient was hospitalized.

7018815-2 | Osteonecrosis
on Sep 16, 2010 Female patient from UNITED STATES , weighting 345.9 lb, was diagnosed with metastasis, bone density abnormal and was treated with Sutent (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Sutent dosage: 50 Mg, Every Other Day. During the same period patient was treated with ZOMETA (Unk) (View Zometa Review and Zometa Label ).

7017471-7 | Cerebral Haemorrhage, Hemiplegia
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: cerebral haemorrhage, hemiplegia on Sep 17, 2010 from FINLAND Additional patient health information: Male patient , 62 years of age, was diagnosed with renal cancer, tumour thrombosis, prophylaxis and. Sutent dosage: 50 Mg 1x/day, 4 Wks, Pause 2 Wks. During the same period patient was treated with KLEXANE (40 Mg, 1x/day) (View Klexane Review and Klexane Label ). Patient was hospitalized.

7017464-X | Blood Pressure Increased, Disease Progression, Renal Cell Carcinoma, Tumour Lysis Syndrome
Adverse event was reported on Sep 17, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, Daily) was diagnosed with renal cell carcinoma and. Location: JAPAN , 61 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, disease progression, renal cell carcinoma, tumour lysis syndrome.

7016918-X | Hepatotoxicity
on Sep 16, 2010 Female patient from CANADA , 83 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). Patient had the following side effects: hepatotoxicity. Sutent dosage: 50 Mg, Unk. Patient was hospitalized.

7016360-1 | Diarrhoea
on Sep 17, 2010 Male patient from UNITED KINGDOM , 65 years of age, was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: diarrhoea. Sutent dosage: 37.5 Mg, 1x/day.

7016336-4 | Blood Count Abnormal, Blood Pressure Increased, Depression, Muscle Spasms
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: blood count abnormal, blood pressure increased, depression (What is depression?), muscle spasms on Sep 15, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 284.4 lb, was diagnosed with metastatic renal cell carcinoma and. Sutent dosage: 50 Mg, 1x/day, X 28 Days Q 42 Days. During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ).

7016333-9 | Blood Potassium Increased, Cardiac Failure, Platelet Count Decreased, Pneumonia, White Blood Cell Count Decreased
Adverse event was reported on Sep 15, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cell carcinoma and. Location: JAPAN , 82 years of age, weighting 132.3 lb, Patient had the following side effects: blood potassium increased, cardiac failure, platelet count decreased, pneumonia (What is pneumonia?), white blood cell count decreased. During the same period patient was treated with PARIET (10 Mg, 1x/day) (View Pariet Review and Pariet Label ), CARNACULIN (50 Mg, 3x/day) (View Carnaculin Review and Carnaculin Label ), ASPIRIN (100 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), TRANEXAMIC ACID (1 Df, 3x/day) (View Tranexamic Acid Review and Tranexamic Acid Label ), DIOVANE (80 Mg, 1x/day) (View Diovane Review and Diovane Label ), HYPEN (200 Mg, 2x/day) (View Hypen Review and Hypen Label ). Patient was hospitalized.

7016330-3 |
on Sep 17, 2010 Male patient from UNITED KINGDOM , 84 years of age, was treated with Sutent (View Usage). . Sutent dosage: 50 Mg, 1x/day.

7016317-0 | Hypertension
on Sep 16, 2010 Female patient from UNITED STATES , weighting 320.3 lb, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension. Sutent dosage: 50 Mg, 1x/day For 28 Days Every 42 Days. During the same period patient was treated with CALTRATE (600 Mg, 1x/day) (View Caltrate Review and Caltrate Label ), CUMADIN (7.5 Mg, 1x/day) (View Cumadin Review and Cumadin Label ), GLYBURIDE (2.5 Mg, 1x/day) (View Glyburide Review and Glyburide Label ), NOVOLIN 70/30 (Sliding Scale) (View Novolin 70/30 Review and Novolin 70/30 Label ).

7016305-4 | Hypertension, Proteinuria, Thrombocytopenia
Patient was taking Sutent (View Usage). Patient had the following side effects: hypertension, proteinuria, thrombocytopenia on Sep 15, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: 50 Mg, 3x/week.

7013737-5 | Blood Glucose Increased, Gout, Hypertension, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Sep 16, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cancer, gout (What is gout?), inflammation, hypertension, glucose tolerance impaired and. Location: UNITED STATES , weighting 244.9 lb, After Sutent was administered, patient had the following side effects: blood glucose increased, gout (What is gout?), hypertension, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with ALLOPURINOL (100 Mg, 2x/day) (View Allopurinol Review and Allopurinol Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), ACEBUTOLOL (600 Mg, Unk) (View Acebutolol Review and Acebutolol Label ), SITAGLIPTIN (100 Mg, Unk) (View Sitagliptin Review and Sitagliptin Label ).

7013736-3 | Hepatic Enzyme Increased, Hypothyroidism, Palmar-plantar Erythrodysaesthesia Syndrome, Skin Ulcer, Thyroid Function Test Abnormal, Tongue Blistering
on Sep 16, 2010 Male patient from UNITED STATES , weighting 168.9 lb, was diagnosed with renal cancer stage iv and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, hypothyroidism, palmar-plantar erythrodysaesthesia syndrome, skin ulcer, thyroid function test abnormal, tongue blistering. Sutent dosage: 50 Mg, 1x/day.

7013721-1 | Blood Pressure Increased, Faeces Discoloured, Haemorrhage, Myocardial Infarction
on Sep 16, 2010 Male patient from UNITED STATES , weighting 211.6 lb, was diagnosed with metastatic renal cell carcinoma, metastasis, gastrooesophageal reflux disease and was treated with Sutent (View Usage). Patient had the following side effects: blood pressure increased, faeces discoloured, haemorrhage, myocardial infarction. Sutent dosage: 25 Mg, 1x/day. During the same period patient was treated with OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ).

7013090-7 | Ascites
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: ascites on Sep 14, 2010 from JAPAN Additional patient health information: Male patient , 54 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: 50 Mg, 1x/day.

7013020-8 | Anaemia, Duodenal Ulcer, Gastrointestinal Haemorrhage, Oesophageal Ulcer
Adverse event was reported on Sep 16, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 1 Df, Cyclic) was diagnosed with renal cancer and. Location: FRANCE , 75 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: anaemia, duodenal ulcer, gastrointestinal haemorrhage, oesophageal ulcer.

7010442-6 | Hypertensive Crisis, Hypotension, Pneumonia, Skin Papilloma
on Aug 08, 2010 Male patient from HONDURAS , 67 years of age, was diagnosed with renal cancer and was treated with Sutent (View Usage). Patient had the following side effects: hypertensive crisis, hypotension, pneumonia (What is pneumonia?), skin papilloma. Sutent dosage: Unk. During the same period patient was treated with DOFETILIDE (View Dofetilide Review and Dofetilide Label ), AMLODIPINE BESILATE (View Amlodipine Besilate Review and Amlodipine Besilate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ). Patient was hospitalized.

7010163-X | Conjunctival Haemorrhage
on Sep 15, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: conjunctival haemorrhage. Sutent dosage: 50 Mg, 1x/day.

7009602-X | Pleural Effusion
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion on Sep 14, 2010 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with renal cancer and. Sutent dosage: 25 Mg, 1x/day. Patient was hospitalized.

7009601-8 | Blood Pressure Decreased, Constipation, Vomiting
Adverse event was reported on Sep 09, 2010 by a Male patient taking Sutent (View Usage) (Dosage: Unk) was diagnosed with neoplasm malignant and. Location: UNITED KINGDOM , 64 years of age, Patient had the following side effects: blood pressure decreased, constipation (What is constipation?), vomiting. Patient was hospitalized.

7007927-5 | Sepsis, Thrombocytopenia
on Sep 13, 2010 Male patient from NETHERLANDS , 76 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: sepsis (What is sepsis?), thrombocytopenia. Sutent dosage: 50 Mg, 1x/day.

7007683-0 | Cerebrovascular Accident
on Sep 13, 2010 Male patient from CANADA , 57 years of age, weighting 211.6 lb, was diagnosed with renal cell carcinoma, hypertension, cough, dyslipidaemia, thrombosis prophylaxis and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Sutent dosage: 50 Mg, 1x/day For 28 Days On, 14 Days Off Per Cycle. During the same period patient was treated with TIAZAC (360 Mg, At Bedtime) (View Tiazac Review and Tiazac Label ), HYCODAN (5 Mg, 1x/day) (View Hycodan Review and Hycodan Label ), LIPITOR (20 Mg, 1x/day) (View Lipitor Review and Lipitor Label ), FRAGMIN (150 Iu/kg, 1x/day) (View Fragmin Review and Fragmin Label ), DOCUSATE SODIUM (Unk) (View Docusate Sodium Review and Docusate Sodium Label ), MOTILIUM ^JANSSEN^ (Unk) (View Motilium ^janssen^ Review and Motilium ^janssen^ Label ), PANTOPRAZOLE (Unk) (View Pantoprazole Review and Pantoprazole Label ), PROCHLORPERAZINE (Unk) (View Prochlorperazine Review and Prochlorperazine Label ). Patient was hospitalized.

7007679-9 | Abdominal Discomfort, Arteriosclerosis Coronary Artery, Cholelithiasis, Depression, Diarrhoea, Disease Progression, Diverticulitis, Diverticulum, Dyspepsia
Patient was taking Sutent (View Usage). Patient had the following side effects: abdominal discomfort, arteriosclerosis coronary artery, cholelithiasis, depression (What is depression?), diarrhoea, disease progression, diverticulitis, diverticulum, dyspepsia on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 269.8 lb, was diagnosed with renal cell carcinoma, metastases to lung, depression (What is depression?), irritability, hypertension and. Sutent dosage: 50 Mg, Daily. During the same period patient was treated with DESVENLAFAXINE (Unk) (View Desvenlafaxine Review and Desvenlafaxine Label ), ATENOLOL (Unk) (View Atenolol Review and Atenolol Label ), VERAPAMIL (Unk) (View Verapamil Review and Verapamil Label ), LISINOPRIL (20 Mg, Unk) (View Lisinopril Review and Lisinopril Label ).